Jefferies Downgrades Exact Sciences to Hold, Raises Price Target to $105

Benzinga · 11/24/2025 12:25
Jefferies analyst Brandon Couillard downgrades Exact Sciences (NASDAQ:EXAS) from Buy to Hold and raises the price target from $90 to $105.